Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

NANO MRNA Co stock price, quote, forecast and news

4571.T
JP3651120002
A0NCX4

Price

169.00 JPY
Today +/-
+0.02 JPY
Today %
+1.79 %
P

NANO MRNA Co stock price

JPY
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the NANO MRNA Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the NANO MRNA Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the NANO MRNA Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze NANO MRNA Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

NANO MRNA Co Stock Price History

DateNANO MRNA Co Price
8/9/2024169.00 JPY
8/8/2024166.00 JPY
8/7/2024163.00 JPY
8/6/2024163.00 JPY
8/5/2024137.00 JPY
8/2/2024172.00 JPY
8/1/2024182.00 JPY
7/31/2024191.00 JPY
7/30/2024189.00 JPY
7/29/2024194.00 JPY
7/26/2024192.00 JPY
7/25/2024192.00 JPY
7/24/2024198.00 JPY
7/23/2024198.00 JPY
7/22/2024196.00 JPY
7/19/2024188.00 JPY
7/18/2024206.00 JPY
7/17/2024198.00 JPY
7/16/2024191.00 JPY
7/12/2024194.00 JPY

NANO MRNA Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into NANO MRNA Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by NANO MRNA Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects NANO MRNA Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of NANO MRNA Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into NANO MRNA Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing NANO MRNA Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on NANO MRNA Co’s growth potential.

NANO MRNA Co Revenue, EBIT and net profit per share

DateNANO MRNA Co RevenueNANO MRNA Co EBITNANO MRNA Co Net Income
2024135.51 M JPY-864.42 M JPY-780 M JPY
2023202.19 M JPY-1.25 B JPY-1.31 B JPY
2022264.03 M JPY-2.06 B JPY-1.88 B JPY
2021313.26 M JPY-1.3 B JPY-2.84 B JPY
2020552.97 M JPY-1.11 B JPY-2.01 B JPY
2019496.73 M JPY-1.8 B JPY-1.81 B JPY
2018259.1 M JPY-5.35 B JPY-5.42 B JPY
2017218.69 M JPY-2.71 B JPY-2.68 B JPY
2016243.34 M JPY-2.08 B JPY-2.54 B JPY
2015675.8 M JPY-1.11 B JPY-207.16 M JPY
2014472.2 M JPY-1.12 B JPY-1.11 B JPY
2013373.8 M JPY-526.8 M JPY-484.4 M JPY
2012346.3 M JPY-333.5 M JPY-398 M JPY
201184.3 M JPY-519.9 M JPY-555.2 M JPY
2010117.8 M JPY-492.7 M JPY-494.8 M JPY
2009353.6 M JPY-531.8 M JPY-524.5 M JPY
2008262.7 M JPY-452.5 M JPY-494 M JPY
2007103.4 M JPY-717.3 M JPY-729.4 M JPY
2006107.9 M JPY-801.6 M JPY-974.3 M JPY
2005113.4 M JPY-502.9 M JPY-509.5 M JPY

NANO MRNA Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M JPY)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M JPY)EBIT (M JPY)EBIT MARGIN (%)NET INCOME (M JPY)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
9612211310710326235311784346373472675243218259496552313264202135
-27.08-7.38-5.31-3.74154.3734.73-66.86-28.21311.907.8026.5443.01-64.00-10.2918.8191.5111.29-43.30-15.65-23.48-33.17
60.4221.3147.79-10.6874.0530.0339.3239.2963.8726.8161.4468.5986.8372.0273.7583.8786.0587.5484.0978.7181.48
5826540111941064633221100290463211157191416475274222159110
-144-232-502-801-717-452-531-492-519-333-526-1,123-1,108-2,082-2,712-5,351-1,802-1,105-1,302-2,061-1,246-864
-150.00-190.16-444.25-748.60-696.12-172.52-150.42-420.51-617.86-96.24-141.02-237.92-164.15-856.79-1,244.04-2,066.02-363.31-200.18-415.97-780.68-616.83-640.00
-141-232-509-974-729-494-524-494-555-398-484-1,113-207-2,537-2,676-5,416-1,808-2,009-2,835-1,881-1,310-780
-64.54119.4091.36-25.15-32.246.07-5.7312.35-28.2921.61129.96-81.401,125.605.48102.39-66.6211.1241.11-33.65-30.36-40.46
12.912.912.912.912.99.913.613.916.822.925.736.640.4642.6243.1143.246.2161.568.2869.9670.0970.3
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The NANO MRNA Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the NANO MRNA Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B JPY)RECEIVABLES (M JPY)OTHER REC. (M JPY)INVENTORIES (M JPY)OTHER CURRENT LIAB. (M JPY)CURRENT ASSETS (B JPY)TANGIBLE ASSETS (M JPY)LONG-T. INVEST. (B JPY)LONG-T. REC. (M JPY)INTANGIBLE ASSETS (M JPY)GOODWILL (M JPY)OTHER NON-CURRENT ASSETS (B JPY)NON-CURRENT ASSETS (B JPY)TOTAL ASSETS (B JPY)LIABILITIESCOMMON STOCK (B JPY)ADDITIONAL PAID-IN CAPITAL (B JPY)RETAINED EARNINGS (M JPY)OTHER EQUITY (k JPY)UNREAL. GAINS/LOSSES (M JPY)EQUITY (B JPY)LIABILITIES (M JPY)PROVISIONS (M JPY)OTHER SHORT-TERM LIAB. (M JPY)SHORT-TERM DEBTS (M JPY)LONG-TERM DEBT PORTION (M JPY)SHORT-TERM REC. (M JPY)LONG-T. LIAB. (B JPY)DEFERRED TAXES (M JPY)OTHER LIAB. (M JPY)LONG-T. LIABILITIES (B JPY)DEBT (B JPY)TOTAL CAPITAL (B JPY)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
0.431.951.231.31.721.761.371.011.872.985.167.2513.7713.7611.776.416.577.476.45.954.444.28
16664184043661527193.635.3441.6817.52103.4194.0124.0711.6327.50.55
221713141615111232039110.35156.35137.76147.75136.872.48103.39107.088.4728.27
2572337431211122689918120351.4149.79275.8151.7332.8576.14138.3333.410.650.18
01801612863112023281137482.2214.7217.73116.22146.15206.59234206.97188.51155.44
0.471.961.411.391.911.961.451.071.983.115.477.5914.2114.3212.446.846.997.926.96.34.674.46
91100168142432292419381939169.1361.59162.457.823.370.154.266.5300
000000000000.10.110.790.130.521.370.820.690.60.890.36
0000000000000000000000
214350453835272026.38110.983.421.850.1513.440.150.150
0000000000000000000000
000.010.010.010.010.010.010.010.510.116.610.210.210.210.210.210.210.210.230.230.25
0.090.110.180.030.090.090.080.070.060.550.136.750.491.070.50.791.581.020.920.831.120.61
0.562.071.61.411.992.041.531.142.043.665.6114.3414.715.3912.947.638.578.947.827.145.785.07
0.471.331.331.582.312.632.672.693.393.585.0810.2410.7710.7711.0911.11.844.140.330.350.120.14
0.451.311.311.562.292.612.652.673.373.565.0610.2210.7510.7611.0711.086.098.389.939.955.55.52
-394-626-1,136-2,110-2,840-3,334-3,858-4,350-4,907-5,276-5,743-6,871-7,025.56-9,405.61-12,091.56-17,549.43-1,719.8-3,724.49-2,752.16-4,687.06-1,369.45-2,135.78
000000000000201100-1120
0000000000019.5607.6127.08-331.17-20.9-8.05-43.964.18-108.18
0.532.021.511.041.761.911.461.021.851.864.413.614.512.1310.074.665.888.777.55.574.253.42
081697491125504017.1113.7125.6812.7512.922.015.261.966.180.25
1420282725231918121316165.876.145.95210.9934.7510.0623.3963.0100
2216413920211043921768684147150.44212.19337.98226.95130.69136.34236.72296.31357.92486.29
000300000000000000000000
0000000000000000000000
36448537523413771121190104150203173.42232.04369.6450.69178.36148.41265.37361.27364.1486.54
0000000001.71.040.54032.482.482.48001.151.111.11
0000000000015.241.433.1815.1310.582.324.888.239.490
000000000016023.3724.124.2924.4824.6824.8750.7449.8748.4454.44
0000000001.71.060.540.033.032.52.512.510.030.061.211.171.16
0.040.040.090.380.230.140.070.120.191.81.210.740.23.262.872.972.690.180.321.571.531.65
0.562.071.61.411.992.041.531.142.043.665.6114.3414.715.3812.947.638.578.947.827.145.785.07
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of NANO MRNA Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand NANO MRNA Co's financial health and stability.

Assets

NANO MRNA Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that NANO MRNA Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of NANO MRNA Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into NANO MRNA Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M JPY)DEPRECIATION (M JPY)DEFERRED TAXES (M JPY)CHANGES IN WORKING CAPITAL (M JPY)NON-CASH ITEM (B JPY)PAID INTEREST (M JPY)PAID TAXES (M JPY)NET CASH FLOW FROM OPERATING ACTIVITIES (M JPY)CAPITAL EXPENDITURES (M JPY)CASH FLOW FROM INVESTING ACTIVITIES (B JPY)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B JPY)INTEREST INCOME AND EXPENSES (M JPY)NET DEBT CHANGE (B JPY)NET CHANGE IN EQUITY (B JPY)CASH FLOW FROM FINANCING ACTIVITIES (B JPY)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M JPY)TOTAL DIVIDENDS PAID (M JPY)NET CHANGE IN CASH FLOW (B JPY)FREE CASH FLOW (M JPY)SHARE-BASED COMPENSATION (M JPY)
200620072008200920102011201220132014201520162017201820192020202120222023
-972-727-491-522-492-552-395-482-1,111-205-2,533-2,672-5,413-1,804-2,006-2,832-1,879-1,308
3071415161617651828212680130
000000000000000000
8752-1045826-704-14415-79796349-242-35103235203
0.170-0.01-0.01-00.030.08-0.020-0.850.530.030.1100.91.53-0.110.05
500000000000000000
111222222213333332
-686-663-588-456-452-579-293-635-1,086-1,120-1,971-2,525-4,927-2,037-1,138-1,200-1,752-1,054
-43-61-18-4-8-3-21-20-27-166-89-177-64-700-60
-0.04-0.06-0.02-0-0.01-0-1.72-0.12-7.06-2.567.38-0.60.21-0.99-0.11-0.87-0.241.21
000000-1.7-0.1-7.03-2.47.47-0.420.28-0.98-0.11-0.87-0.241.21
000000000000000000
0.3-0.300001.690003000-001.150
0.51.440.640.080.041.360.292.339.580.50.010.090.023.442.170-00
0.81.140.640.080.11.451.922.339.580.53.10.090.023.382.16-0.011.150
00005387-530-3-39800-52-2-1100
000000000000000000
0.070.420.04-0.39-0.360.87-0.091.671.58-2.988.4-3.06-4.70.380.91-2.08-0.790.21
-729.3-724.4-606.8-461.1-460.1-582.7-314.9-655.7-1,113.7-1,287.12-2,060.24-2,702.75-4,991.67-2,044.56-1,138.89-1,200.32-1,759.21-1,054.85
000000000000000000

NANO MRNA Co stock margins

The NANO MRNA Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of NANO MRNA Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for NANO MRNA Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the NANO MRNA Co's sales revenue. A higher gross margin percentage indicates that the NANO MRNA Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the NANO MRNA Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the NANO MRNA Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the NANO MRNA Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the NANO MRNA Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the NANO MRNA Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

NANO MRNA Co Margin History

NANO MRNA Co Gross marginNANO MRNA Co Profit marginNANO MRNA Co EBIT marginNANO MRNA Co Profit margin
202481.88 %-637.91 %-575.61 %
202378.94 %-616.26 %-648.39 %
202284.36 %-780.62 %-712.67 %
202187.75 %-415.91 %-905.24 %
202085.9 %-199.97 %-363.43 %
201983.92 %-362.83 %-364.08 %
201873.81 %-2,065.42 %-2,090.65 %
201772.09 %-1,240.19 %-1,223.65 %
201687.01 %-855.86 %-1,042.62 %
201568.65 %-163.99 %-30.65 %
201461.41 %-237.84 %-235.85 %
201326.99 %-140.93 %-129.59 %
201263.9 %-96.3 %-114.93 %
201139.38 %-616.73 %-658.6 %
201039.81 %-418.25 %-420.03 %
200930.06 %-150.4 %-148.33 %
200874 %-172.25 %-188.05 %
200711.32 %-693.71 %-705.42 %
20060.37 %-742.91 %-902.97 %
200547.8 %-443.47 %-449.29 %

NANO MRNA Co Stock Sales Revenue, EBIT, Earnings per Share

The NANO MRNA Co earnings per share therefore indicates how much revenue NANO MRNA Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue NANO MRNA Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates NANO MRNA Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of NANO MRNA Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating NANO MRNA Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

NANO MRNA Co Revenue, EBIT and net profit per share

DateNANO MRNA Co Sales per ShareNANO MRNA Co EBIT per shareNANO MRNA Co Earnings per Share
20241.93 JPY-12.3 JPY-11.1 JPY
20232.88 JPY-17.78 JPY-18.7 JPY
20223.77 JPY-29.46 JPY-26.9 JPY
20214.59 JPY-19.08 JPY-41.53 JPY
20208.99 JPY-17.98 JPY-32.68 JPY
201910.75 JPY-39 JPY-39.14 JPY
20186 JPY-123.87 JPY-125.39 JPY
20175.07 JPY-62.91 JPY-62.07 JPY
20165.71 JPY-48.86 JPY-59.53 JPY
201516.7 JPY-27.39 JPY-5.12 JPY
201412.9 JPY-30.69 JPY-30.43 JPY
201314.54 JPY-20.5 JPY-18.85 JPY
201215.12 JPY-14.56 JPY-17.38 JPY
20115.02 JPY-30.95 JPY-33.05 JPY
20108.47 JPY-35.45 JPY-35.6 JPY
200926 JPY-39.1 JPY-38.57 JPY
200826.54 JPY-45.71 JPY-49.9 JPY
20078.02 JPY-55.6 JPY-56.54 JPY
20068.36 JPY-62.14 JPY-75.53 JPY
20058.79 JPY-38.98 JPY-39.5 JPY

NANO MRNA Co business model

NANO MRNA Co is one of the most popular companies on Eulerpool.com.

NANO MRNA Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

NANO MRNA Co historical P/E ratio, EBIT, and P/S ratio.

NANO MRNA Co shares outstanding

The number of shares was NANO MRNA Co in 2023 — This indicates how many shares 70.092 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue NANO MRNA Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates NANO MRNA Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of NANO MRNA Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating NANO MRNA Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

NANO MRNA Co Stock splits

In NANO MRNA Co's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for NANO MRNA Co.

NANO MRNA Co list of shareholders

%
Name
Stocks
Change
Date
2.36 % Shin-Etsu Chemical Co Ltd1,660,00009/30/2023
1.31 % Nakatomi (Ichiro)923,600-30,4009/30/2023
1.07 % Noritsu Koki Co Ltd750,00009/30/2023
0.91 % Keiji Kensetsu Company Ltd.640,90009/30/2023
0.90 % State Street Global Advisors (US)634,20014,1002/29/2024
0.88 % SBI Securities Co., Ltd.615,907-315,0899/30/2023
0.87 % Kimura (Shoji)610,00009/30/2023
0.71 % Whiz Partners Inc.500,00006/12/2023
0.65 % Nomura Securities Co., Ltd.458,415-219,1859/30/2023
0.57 % Daiwa Securities Co., Ltd.402,400-53,3009/30/2023
1
2

NANO MRNA Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
KOSE Stock
KOSE
SupplierCustomer0,550,870,720,760,700,04
Nippon Kayaku Stock
Nippon Kayaku
SupplierCustomer0,400,730,540,510,28-0,31
NOF Stock
NOF
SupplierCustomer0,070,710,500,570,75-0,59
Vascular Biogen Stock
Vascular Biogen
SupplierCustomer-0,200,360,320,690,87-0,35
1

Most common questions regarding NANO MRNA Co

What is the P/E ratio of NANO MRNA Co 2024?

The NANO MRNA Co P/E ratio is -15.23.

What is the P/S ratio of NANO MRNA Co 2024?

The NANO MRNA Co P/S ratio is 87.67.

What is the AlleAktien quality score of NANO MRNA Co?

The AlleAktien quality score for NANO MRNA Co is 2/10.

What is the revenue of NANO MRNA Co 2024?

The NANO MRNA Co revenue is 135.51 M JPY.

How high is the profit of NANO MRNA Co 2024?

The NANO MRNA Co profit is -780 M JPY.

What is the business model of NANO MRNA Co

No history available for NANO MRNA Co.

What is the NANO MRNA Co dividend?

NANO MRNA Co pays a dividend of 0 JPY distributed over payouts per year.

How often does NANO MRNA Co pay dividends?

The dividend cannot currently be calculated for NANO MRNA Co or the company does not pay out a dividend.

What is the NANO MRNA Co ISIN?

The ISIN of NANO MRNA Co is JP3651120002.

What is the NANO MRNA Co WKN?

The WKN of NANO MRNA Co is A0NCX4.

What is the NANO MRNA Co ticker?

The ticker of NANO MRNA Co is 4571.T.

How much dividend does NANO MRNA Co pay?

Over the past 12 months, NANO MRNA Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NANO MRNA Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of NANO MRNA Co?

The current dividend yield of NANO MRNA Co is .

When does NANO MRNA Co pay dividends?

NANO MRNA Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NANO MRNA Co?

NANO MRNA Co paid dividends every year for the past 0 years.

What is the dividend of NANO MRNA Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is NANO MRNA Co located?

NANO MRNA Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von NANO MRNA Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NANO MRNA Co from 8/10/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 8/10/2024.

When did NANO MRNA Co pay the last dividend?

The last dividend was paid out on 8/10/2024.

What was the dividend of NANO MRNA Co in the year 2023?

In the year 2023, NANO MRNA Co distributed 0 JPY as dividends.

In which currency does NANO MRNA Co pay out the dividend?

The dividends of NANO MRNA Co are distributed in JPY.

All fundamentals about NANO MRNA Co

Our stock analysis for NANO MRNA Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NANO MRNA Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.